Patients want information shared openly but at no cost

Nearly 75 percent of American adults surveyed believe it is very important that their critical health information should be easily shared between physicians, hospitals and other healthcare providers and most (87 percent) are against any associated fees, according to a survey released by the Society of Participatory Medicine and conducted by ORC International.

Nearly 20 percent of those surveyed felt that they or a family member experienced a problem receiving medical care because their health records could not be shared between different healthcare providers.

“What this survey points out is that when critical health information can’t be shared across medical practices and hospitals, patients are put at risk,” said Daniel Z. Sands, MD, co-founder and co-chair of the Society of Participatory Medicine, in a release.

Several independent sources have noted that doctors are forced to pay between $5,000 to $50,000 to set up connections allowing them to transmit information to blood and pathology laboratories, health information exchanges or governments. Sometimes additional fees are charged each time a doctor sends or receives data.

“We have the technology," Sands said. "What we need is for healthcare providers and systems developers to put patient interests ahead of business needs. None of them would exist were it not for the patients.”

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.